News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.

Professor Paul Workman comments on further draft guidance for olaparib
Professor Paul Workman, Cheif Executive of the ICR has commented on today’s decision on olaparib for women with BRCA mutated ovarian cancer in further draft guidance from NICE.
Creative types
In the fifth and final essay short-listed for the ICR's Mel Greaves Science Writing Prize 2015, Dr Chris Tape discovers what it's like to communicate science to millions of people.
Lucy’s Gratitude Walk to raise funds for the ICR
Lucy O'Donnell, a mother of three teenagers, and her friend Lucinda will walk the South Downs Way in support of the ICR.
Professor Kevin Harrington to star in BBC2’s Trust me, I’m a Doctor
The ICR’s Professor Kevin Harrington is to feature in the BBC2 programme Trust Me, I’m a Doctor on Wednesday 29 July.

Drugs for worms and river blindness could treat breast cancer
Cheap drugs which treat parasitic worms and conditions such as river blindness could be used for women with a type of breast cancer that often fails to respond to standard therapies.
Socrates and apoptosis
In the fourth of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, Dr Daniel Nava Rodrigues offers similarities between our bodies and city-states – how are the cells in our bodies policed?
Oestrogen-suppressing drugs substantially reduce breast cancer deaths
A class of hormonal drugs – already used in the clinic – reduce the risk of death in postmenopausal women with the most common type of breast cancer.

New ‘chemotherapy booster’ could treat lung and pancreatic cancer
A new drug that blocks cancer’s escape route from chemotherapy could be used to treat deadly lung and pancreatic cancers, new research reports.

Resistance to cancer drug found to occur naturally in the breast
Study finds the genetic mutations which drive resistance to some targeted cancer drugs are present in breast cancer cells right from the beginning of treatment.

New ‘TripAdvisor’ site to address use of substandard biomedical research tools
A new 'TripAdvisor-style' website will help biomedical researchers pick the best chemical probes for the job – improving research and treatment of disease.

Word processing for mankind
In the third of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, Kevin Litchfield discusses the potential consequences of cutting-edge genetics research.
Professor Stan Kaye honoured with students at annual awards
Professor Stan Kaye, a pioneer in experimental clinical trials world-class translational research, was honoured alongside students and former staff members at our annual celebration, the ICR Awards Ceremony.
